INS and Hypoglycemia: The treatment regimen with vildagliptin along with insulin (VIL-INS) for 24 months was safe and effective in reducing glycated hemoglobin (HbA1c) levels, the dose and frequency of insulin injections, and the risk of hypoglycemia in patients with T2DM [7].